Prosthetic Valve Endocarditis After Aortic Valve Replacement: Differences Between Biological and Mechanical Prostheses

被引:0
作者
Timmermans, Naomi [1 ]
Lam, Ka Yan [1 ]
van Straten, Albert [1 ]
van't Veer, Marcel [2 ]
Soliman-Hamad, Mohamed [1 ,3 ]
机构
[1] Catharina Hosp, Heart Ctr, Dept Cardiothorac Surg, Eindhoven, Netherlands
[2] Eindhoven Univ Technol, Heart Ctr, Dept Biomed Engn, Eindhoven, Netherlands
[3] Catharina Hosp, Dept Cardiothorac Surg, Michelangelolaan 2,POB 1350, NL-5602 ZA Eindhoven, Netherlands
关键词
Aortic valve replacement; Prosthetic valve endocarditis; Re-intervention; SURGERY; DIAGNOSIS; OUTCOMES; SOCIETY; TRENDS;
D O I
10.1016/j.hlc.2023.11.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Prosthetic valve endocarditis (PVE) is the most severe form of infective endocarditis associated with a high mortality rate. Whether PVE affects biological and mechanical aortic valves to the same extent remains controversial. This study aimed to compare the incidence of re-intervention because of PVE between bioprosthetic and mechanical valves. Methods Patients undergoing isolated surgical aortic valve replacement (AVR) or combined AVR in a single cardiac surgery centre between January 1998 and December 2019 were analysed. All patients who underwent re-intervention because of PVE were identified. The primary endpoint was the rate of explants. Freedom from re-intervention and variables associated with re-intervention were analysed using Cox regression analysis including correction for competing risk. Results During the study period, 5,983 aortic valve prostheses were implanted, including 3,620 biological (60.5%) and 2,363 mechanical (39.5%) prostheses. The overall mean follow-up period was 7.365.3 years (median, 6.5; IQR 2.9-11.2 years). The rate of re-intervention for PVE in the biological group was 1.5% (n=54) compared with 1.7% (n=40) in the mechanical group (p=0.541). Cox regression analysis revealed that younger age (HR 0.960, 95% CI 0.942-0.979; p,0.001), male sex (HR 2.362, 95% CI 1.384-4.033; p=0.002), higher creatinine (HR 1.002, 95% CI 0.999-1.004; p=0.057), and biological valve prosthesis (HR 2.073, 95% CI 1.258-3.414; p=0.004) were associated with re-intervention for PVE. After correction for competing risk of death, biological valve prosthesis was significantly associated with a higher rate of reintervention for PVE (HR 2.011, 95% CI 1.177-3.437; p=0.011). Conclusions According to this single -centre, observational, retrospective cohort study, AVR using biological prosthesis is associated with re-intervention for PVE compared to mechanical prosthesis. Further investigations are needed to verify these findings.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 24 条
  • [1] Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis
    Anantha-Narayanan, Mahesh
    Reddy, Yogesh N., V
    Sundaram, Varun
    Murad, Mohammad Hassan
    Erwin, Patricia J.
    Baddour, Larry M.
    Schaff, Hartzell, V
    Nishimura, Rick A.
    [J]. HEART, 2020, 106 (18) : 1413 - 1419
  • [2] Trifecta Versus Perimount Magna Ease Aortic Valve Prostheses
    Biancari, Fausto
    Valtola, Antti
    Juvonen, Tatu
    Husso, Annastiina
    Dahlbacka, Sebastian
    Laakso, Teemu
    Jalava, Maina P.
    Tauriainen, Tuomas
    Ahvenvaara, Tuomas
    Kinnunen, Eeva-Maija
    Niemela, Matti
    Makikallio, Timo
    Eskola, Markku
    Virtanen, Marko P. O.
    Maaranen, Pasi
    Rosato, Stefano
    Anttila, Vesa
    Vento, Antti
    Airaksinen, Juhani
    Raivio, Peter
    [J]. ANNALS OF THORACIC SURGERY, 2020, 110 (03) : 879 - 888
  • [3] Long-Term Safety and Effectiveness of Mechanical Versus Biologic Aortic Valve Prostheses in Older Patients Results From the Society of Thoracic Surgeons Adult Cardiac Surgery National Database
    Brennan, J. Matthew
    Edwards, Fred H.
    Zhao, Yue
    O'Brien, Sean
    Booth, Michael E.
    Dokholyan, Rachel S.
    Douglas, Pamela S.
    Peterson, Eric D.
    [J]. CIRCULATION, 2013, 127 (16) : 1647 - +
  • [4] Aortic valve replacement in patients aged 50 to 70 years: Improved outcome with mechanical versus biologic prostheses
    Brown, Morgan L.
    Schaff, Hartzell V.
    Lahr, Brian D.
    Mullany, Charles J.
    Sundt, Thoralf M.
    Dearani, Joseph A.
    McGregor, Christopher G.
    Orszulak, Thomas A.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (04) : 878 - 884
  • [5] Better anticoagulation control improves survival after valve replacement
    Butchart, EG
    Payne, N
    Li, HH
    Buchan, K
    Mandana, K
    Grunkemeier, GL
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (04) : 715 - 723
  • [6] Pacemaker Lead Endocarditis Investigated with Intracardiac Echocardiography: Factors Modulating the Size of Vegetations and Larger Vegetation Embolic Risk during Lead Extraction
    Caiati, Carlo
    Pollice, Paolo
    Lepera, Mario Erminio
    Favale, Stefano
    [J]. ANTIBIOTICS-BASEL, 2019, 8 (04):
  • [7] The Diagnosis and Treatment of Pacemaker-Associated Infection
    Doring, Michael
    Richter, Sergio
    Hindricks, Gerhard
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (26): : 445 - +
  • [8] Aortic valve surgery: Marked increases in volume and significant decreases in mechanical valve use-an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database
    Dunning, Joel
    Gao, Haiyan
    Chambers, John
    Moat, Neil
    Murphy, Gavin
    Pagano, Domenic
    Ray, Simon
    Roxburgh, James
    Bridgewater, Ben
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 142 (04) : 776 - U304
  • [9] Infective endocarditis in the Netherlands: current epidemiological profile and mortality An analysis based on partial ESC EORP collected data
    El Kadi, S.
    van den Buijs, D. M. F.
    Meijers, T.
    Gilbers, M. D.
    Bekkers, S. C. A. M.
    van Melle, J. P.
    Riezebos, R. K.
    Blok, W. L.
    Tanis, W.
    Wahadat, A. R.
    Roos-Hesselink, J. W.
    van der Spoel, T. I. G.
    Chamuleau, S. A. J.
    Kamp, O.
    [J]. NETHERLANDS HEART JOURNAL, 2020, 28 (10) : 526 - 536
  • [10] 2017 ESC/EACTS Guidelines for the management of valvular heart disease
    Falk, Volkmar
    Baumgartner, Helmut
    Bax, Jeroen J.
    De Bonis, Michele
    Hamm, Christian
    Holm, Per Johan
    Iung, Bernard
    Lancellotti, Patrizio
    Lansac, Emmanuel
    Rodriguez Munoz, Daniel
    Rosenhek, Raphael
    Sjogren, Johan
    Tornos Mas, Pilar
    Vahanian, Alec
    Walther, Thomas
    Wendler, Olaf
    Windecker, Stephan
    Luis Zamorano, Jose
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 52 (04) : 616 - 664